REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Centrum Diagnostyki Medycznej Endomed Sp. z o.o. sp. k. (Poland)

Main Activities: Ambulatory Health Care Services
Full name: Centrum Diagnostyki Medycznej Endomed Sp. z o.o. sp. k. Profile Updated: October 11, 2021
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Polish Download a sample report

Centrum Diagnostyki Medycznej Endomed Sp. z o.o. sp. k. is a company based in Poland, with its head office in Gdansk. It operates in the Ambulatory Health Care Services industry. The enterprise was incorporated on February 20, 2019. In 2020, the company reported a net sales revenue drop of 13.81%. A growth of 29.9% was recorded in its total assets.

Headquarters
Ul. Dabrowki 56
Gdansk; Pomorskie; Postal Code: 80-041

Contact Details: Purchase the Centrum Diagnostyki Medycznej Endomed Sp. z o.o. sp. k. report to view the information.

Website: http://www.endomed.pl

Basic Information
Outstanding Shares:
Purchase the Centrum Diagnostyki Medycznej Endomed Sp. z o.o. sp. k. report to view the information.
Incorporation Date:
February 20, 2019
Key Executives
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Limited Partner
Purchase this report to view the information.
Limited Partner
Purchase this report to view the information.
Limited Partner
Purchase this report to view the information.
Limited Partner
Company Performance
Financial values in the chart are available after Centrum Diagnostyki Medycznej Endomed Sp. z o.o. sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-13.81%▼
Total operating revenue
-12%▼
Operating profit (EBIT)
N/A
EBITDA
-26.15%▼
Net Profit (Loss) for the Period
N/A
Total assets
29.9%▲
Total equity
-32.16%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
403.95%▲
Quick Ratio
0.22%▲

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo